missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DR6 Synthetic Peptide
Description
This peptide corresponds to 15 amino acids of human DR6. PEP-0055 can be used as a blocking peptide with polyclonal antibody PA5-19930.
DR6 is widely expressed in human tissues and cell lines. The ligand for DR6 has not been identified. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNF-R1 and Fas. Several novel death receptors including DR3, DR4, and DR5 were recently identified. A new death domain containing receptor in the TNFR family was cloned recently and termed DR6 for death receptor-6. Like TNF-R1, DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-kappa-B and JNK.
Spécifications
Spécifications
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d'enregistrement | O75509 |
| Nom usuel | DR6 |
| Concentration | 200 μg/mL |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Alias du gène | AA959878; BM-018; CD358; Death receptor 6; Death receptor-6; DR6; MGC31965; R74815; sCD358; sDR6; soluble CD358; soluble DR6; TNF receptor superfamily member 21; TNFR-related death receptor 6; TNFR-related death receptor-6; Tnfrsf21; TR7; Tumor necrosis factor receptor superfamily member 21; tumor necrosis factor receptor superfamily, member 21; UNQ437/PRO868 |
| Symbole de gène | TNFRSF21 |
| Lyophilisé | No |
| Afficher plus de résultats |